8-KEarnings & ResultsExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Financial Results (Jul 19, 2005)

Filed July 19, 2005For Securities:JNJ

Summary

Johnson & Johnson (JNJ) filed a Form 8-K on July 19, 2005, to report its financial results for the second quarter ended July 3, 2005. The filing includes a press release and supplementary sales data that detail the company's performance during the period. Investors can find information regarding sales and earnings directly within the attached exhibits. This report serves as the official announcement of JNJ's quarterly financial outcomes, providing a snapshot of the company's operational and financial condition for the specified quarter. Key takeaways for investors revolve around the sales and earnings figures released. While the 8-K itself is a reporting mechanism, the attached press release and supplementary data are the critical components for analyzing JNJ's performance. Investors should review these exhibits to understand the company's revenue generation, profitability, and any trends or significant developments impacting its financial health during the second quarter of 2005.

Key Highlights

  • 1Filing reports Johnson & Johnson's financial results for the second quarter ended July 3, 2005.
  • 2The 8-K filing includes a press release announcing sales and earnings for the quarter.
  • 3Supplementary unaudited comparative sales data and condensed consolidated statement of earnings are provided.
  • 4Exhibit 99.15 is the press release dated July 19, 2005.
  • 5Exhibit 99.20 contains unaudited comparative supplementary sales data and condensed consolidated statement of earnings.
  • 6The Chief Accounting Officer, Stephen J. Cosgrove, signed the report.
  • 7This filing is an event-driven report on the company's financial condition and results of operations.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially report Johnson & Johnson's sales and earnings results for the second quarter ended July 3, 2005, as announced in their press release.

The actual sales and earnings numbers are detailed in the exhibits attached to this 8-K filing, specifically in the press release (Exhibit 99.15) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.20).

This item signifies that the company is disclosing material information regarding its performance (operations) and its financial standing as of the end of the reporting period (financial condition), typically through the release of quarterly earnings.

Stephen J. Cosgrove is Johnson & Johnson's Chief Accounting Officer. His signature confirms that the information presented in the 8-K filing has been reviewed and is being officially submitted on behalf of the company in accordance with SEC regulations.